Theriva Biologics, Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Theriva Biologics, Inc. (TOVX) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 510.00 thousand shares for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2024-11-12
- Theriva Biologics, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2024-09-30 was 510.00K shares.
- Theriva Biologics, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2019-09-30 was 0.00 shares.
- Theriva Biologics, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2019-06-30 was 0.00 shares.
- Theriva Biologics, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2019-03-31 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month |
|---|---|---|---|
| 2024-09-30 | 510.00K shares 10-Q · filed 2024-11-12 | 510.00K shares 10-Q · filed 2024-11-12 | |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-04 | 0.00 shares 10-Q · filed 2019-11-04 | |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-08 | 0.00 shares 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-08 | ||
| 2018-09-30 | 0.00 shares 10-Q · filed 2019-11-04 | 0.00 shares 10-Q · filed 2019-11-04 | |
| 2018-06-30 | 0.00 shares 10-Q · filed 2019-08-08 | 0.00 shares 10-Q · filed 2019-08-08 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-05-08 | ||
| 2017-09-30 | 0.00 shares 10-Q · filed 2018-11-08 | 0.00 shares 10-Q · filed 2018-11-08 | |
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-08 | 0.00 shares 10-Q · filed 2018-08-08 | |
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-08 | ||
| 2016-09-30 | 0.00 shares 10-Q · filed 2017-11-01 | 0.00 shares 10-Q · filed 2017-11-01 | |
| 2016-06-30 | 2.91M shares 10-Q · filed 2017-08-03 | 1.73M shares 10-Q · filed 2017-08-03 | |
| 2015-09-30 | 1.61M shares 10-Q · filed 2016-11-01 | 0.00 shares 10-Q · filed 2016-11-01 | |
| 2014-09-30 | 0.00 shares 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |